-
News Agency News Aggregator Journalist/Editor Broking House Others
Intraday Stock Alert #CAPLIPOINT - 657.5 Target 1: 664.05 Target 2: 668.1 Target 3: 674.7 SL: 632.5 Time: 13.03.2023 9:55 am Alerts are for educational purpose only. Tools: Live Telegram Alerts:
#OnCNBCTV18 | Consistently gaining #marketshare with previous approvals, says Vivek Partheeban, COO, Caplin Point Labs. Tells @_soniashenoy & @ekta_batra that company is looking at organic #growth in Caplin Steriles. Adds that it can grow to Rs 300 cr in #FY24
Caplin Point Laboratories trades higher as its arm gets USFDA`s nod for Thiamine Hydrochloride Injection #StockMarket #PharmaSector #CaplinPointLaboratoriesLtd #Investmentguruindia
Stocks In News | Caplin Point in focus as the co's unit gets U.S. FDA nod for thiamine hydrochloride jab (From Agencies) #CaplinPoint @US_FDA
CAPLIN POINT LABORATORIES LTD - UNIT GETS USFDA APPROVAL FOR THIAMINE HYDROCHLORIDE INJECTION
Caplin Point gets @US_FDA approval for Thiamine Hydrochloride Injection Alert: Thiamine Hydrochloride Injection treats Thiamine (Vitamin B1) deficiency or Beriberi
Caplin Point Laboratories gains as its arm gets USFDA`s approval for Rocuronium Bromide Injection #StockMarket #PharmaSector #CaplinPointLaboratories #USFDA #Investmentguruindia
#JustIn | Caplin Point gets US FDA nod for its abbreviated new drug application Rocuronium Bromide Injection Alert: Rocuronium Bromide Injection is indicated as an adjunct to general anaesthesia
Intraday Stock Alert #CAPLIPOINT - 680.9 Target 1: 687.7 Target 2: 691.9 Target 3: 698.7 SL: 655 Time: 22.02.2023 9:20 am Alerts are for educational purpose only. Tools: Live Telegram Alerts:
#CAPPL CAPLIN POINT LABORATORIES RESULT
Caplin Point Laboratories Ltd.: Result is ok #NirmalBang #resultupdate #nse #bse #Q3 #quarterlyresults #StockMarkets #stockmarketindia #earnings #earningreview #CaplinPointLaboratories
Caplin Point Laboratories Ltd consolidated Q3 FY2023 net profit up at Rs. 97.48 crores #CaplinPointLaboratories #Q3FY23 #9MFY23 #ResultUpdate
CAPLIN POINT LABORATORIES: Q3 EBITDA 1.24B RUPEES VS 1.10B (YOY) || Q3 EBITDA MARGIN 32% VS 32.9% (YOY)
CAPLIN POINT LABORATORIES LTD:Q3 CONS NET PROFIT 974M RUPEES VS 749M(YOY);916M(QOQ)|| Q3 REVENUE 3.72B RUPEES VS 3.26B(YOY);3.59B(QOQ)
Good nos -11/2 till 2pm Kirloskar industries Rev 1606cr vs 935cr PBT 183cr vs 113cr,flat QoQ Caplin Point Rev 372cr vs 326cr PBT 112cr vs 99cr,flat QoQ Usha Martin Rev 833cr vs 712cr PBT 110cr vs 83cr,q2 100cr Salasar Techno Rev 240cr vs 173cr PBT 14.4cr vs 9.5cr,q2 10.6cr
#3QWithCNBCTV18 | Caplin Point reports #Q3 results ➡️Net profit up 30% at Rs 97.5 cr vs Rs 75 cr (YoY) ➡️Revenue up 14.1% at Rs 372.1 cr vs Rs 326.2 cr (YoY) ➡️EBITDA up 8.4% at Rs 109.4 cr vs Rs 101 cr (YoY) ➡️Margin at 29.4% vs 31% (YoY)
Intraday Stock Alert #CAPLIPOINT - 706.15 Target 1: 713.2 Target 2: 717.55 Target 3: 724.6 SL: 679.3 Time: 10.02.2023 9:20 am Alerts are for educational purpose only. Tools: Live Telegram Alerts:
Trade Alerts, Trade Ideas and Crypto 🇺🇸
CAPLIPOINT Long at Daily Trendline 📈📉💹📊 via ➡️
✨#SPLMidcapStocks शॉर्ट टर्म, पोजीशनल और लॉन्ग टर्म के लिए एक्सिस सिक्योरिटीज के राजेश पालविया से 3 बेहतरीन #MidcapStocks Short Term- Satin Creditcare Positional Term- Mrs. Bectors Food Specialities Long Term- Caplin Point Lab @rajeshpalviya @AshishZBiz @VarunDubey85
-